Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
Immune cell therapy tested for early lung cancer safety
Disease control Not yet recruitingThis early-stage study tests the safety of a therapy using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), to treat early-stage non-small cell lung cancer. The study will enroll 50 people with multiple lung nodules that have not gone away after a year.…
Phase: EARLY_PHASE1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Dual-Purpose drug: could roxadustat fight both anemia and muscle wasting in dialysis?
Disease control Not yet recruitingThis study looks at whether roxadustat, a drug used to treat anemia in kidney disease, can also help reduce muscle loss (sarcopenia) in people on hemodialysis. About 60 adults with end-stage kidney disease and anemia will receive either roxadustat or standard treatment. Researche…
Phase: PHASE4 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New pain drug may stop chronic ache after lung surgery
Symptom relief Not yet recruitingThis study compares two pain medicines given through an IV pump after lung surgery. The goal is to see if oliceridine can prevent chronic pain better than the standard drug, sufentanil. About 320 adults having keyhole lung surgery will take part. The main focus is on pain levels …
Phase: PHASE4 • Sponsor: Tianjin Medical University General Hospital • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC